Primary biliary cholangitis with normal alkaline phosphatase: A neglected clinical entity challenging current guidelines.

Terziroli Beretta-Piccoli, Benedetta; Stirnimann, Guido; Mertens, Joachim; Semela, David; Zen, Yoh; Mazzucchelli, Luca; Voreck, Anja; Kolbus, Norbert; Merlo, Elisabetta; Di Bartolomeo, Claudia; Messina, Paola; Cerny, Andreas; Costantini, Silvia; Vergani, Diego; Mieli-Vergani, Giorgina (2021). Primary biliary cholangitis with normal alkaline phosphatase: A neglected clinical entity challenging current guidelines. Journal of autoimmunity, 116(102578), p. 102578. Elsevier 10.1016/j.jaut.2020.102578

[img] Text
1-s2.0-S0896841120302110-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (3MB) | Request a copy

BACKGROUND & AIM

The diagnosis of primary biliary cholangitis (PBC), an uncommon immune-mediated cholestatic liver disease, is based on positive circulating anti-mitochondrial (AMA) and/or PBC-specific anti-nuclear autoantibodies (ANA), coupled with elevated serum alkaline phopsphatase (ALP) levels. Timely initiation of treatment with ursodeoxycholic acid prevents progression to cirrhosis and liver failure. We aimed at investigating liver histology in patients with normal ALP level and positive AMA and/or PBC-specific ANA.

METHODS

We searched the Swiss PBC Cohort Study database, which includes subjects with positive PBC autoimmune serology and normal ALP levels, for patients who underwent a liver biopsy. Histological slides were centrally reviewed by an expert liver pathologist, and sera were centrally re-tested for AMA and ANA.

RESULTS

30 patients were included; 90% females, median age 53 (range 27-72) years. Twenty-four (80%) had liver histology typical for (n = 2), consistent with (n = 16) or suggestive of (n = 6) PBC, including three of four AMA-negative ANA-positive patients. Among 22 ursodeoxycholic acid treated patients, 14 had elevated GGT levels before treatment; a significant decrease of the median GGT level between pre- (1.46 x ULN) and post- (0.43 x ULN) treatment (p = 0.0018) was observed.

CONCLUSIONS

In our series, a high proportion of AMA positive patients with normal ALP levels have PBC. For the first time we show histological diagnosis of PBC in AMA-negative/PBC-specific ANA-positive subjects and the potential role of GGT as a biomarker in PBC patients with normal baseline ALP levels. Current guidelines for the diagnosis of PBC do not cover the whole extent of PBC presentation, with important clinical implications in terms of timely treatment initiation.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Hepatology
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine

UniBE Contributor:

Stirnimann, Guido

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0896-8411

Publisher:

Elsevier

Language:

English

Submitter:

Rahel Fuhrer

Date Deposited:

18 Dec 2020 16:23

Last Modified:

30 Dec 2020 01:33

Publisher DOI:

10.1016/j.jaut.2020.102578

PubMed ID:

33229138

Uncontrolled Keywords:

Anti-mitochondrial antibody Anti-nuclear antibody alkaline phosphatase Gamma-glutamyltransferase Liver histology Primary biliary cholangitis

BORIS DOI:

10.7892/boris.148666

URI:

https://boris.unibe.ch/id/eprint/148666

Actions (login required)

Edit item Edit item
Provide Feedback